These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7763301)

  • 1. The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studies.
    Coley HM; Brooks N; Phillips DH; Hewer A; Jenkins TC; Jarman M; Judson IR
    Biochem Pharmacol; 1995 May; 49(9):1203-12. PubMed ID: 7763301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable analogues of the antitumour agent trimelamol retain in vitro cytotoxicity in drug-sensitive and resistant rodent and human cell lines.
    Coley HM; Jarman M; Brooks N; Thornton TJ; Judson IR
    Eur J Cancer; 1994; 30A(12):1827-36. PubMed ID: 7880614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
    Ross D; Langdon SP; Gescher A; Stevens MF
    Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(Hydroxymethyl) melamines.
    Coley HM
    Gen Pharmacol; 1997 Feb; 28(2):177-82. PubMed ID: 9013191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol.
    Coley HM; Jarman M; Brooks N; Kubota T; Goddard PM; Jones M; Lee N; Owens MD; Halbert GW; Judson IR
    Int J Cancer; 1996 Nov; 68(3):356-63. PubMed ID: 8903478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N2,N4,N6-tri(hydroxymethyl)-N2,N4,N6-trimethylmelamine (trimelamol) is an efficient DNA cross-linking agent in vitro.
    Jackson C; Hartley JA; Jenkins TC; Godfrey R; Saunders R; Thurston DE
    Biochem Pharmacol; 1991 Nov; 42(11):2091-7. PubMed ID: 1958227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts.
    Coley HM; Jarman M; Jones M; Sargent JM; Kubota T; Lee NC; Goddard PM; Elgie AW; Williamson C; Taylor CG; Judson IR
    Anticancer Res; 1996; 16(4A):1851-5. PubMed ID: 8712712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
    Coley HM; Mongelli N; D'Incalci M
    Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl.
    Jarman M; Coley HM; Judson IR; Thornton TJ; Wilman DE; Abel G; Rutty CJ
    J Med Chem; 1993 Dec; 36(26):4195-200. PubMed ID: 8277501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of DNA damage by methylmelamines and formaldehyde.
    Ross WE; McMillan DR; Ross CF
    J Natl Cancer Inst; 1981 Jul; 67(1):217-21. PubMed ID: 6788992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents.
    Gibson NW; Zlotogorski C; Erickson LC
    Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior efficacy of trimelamol to hexamethylmelamine in human ovarian cancer xenografts.
    Boven E; Nauta MM; Schlüper HM; Erkelens CA; Pinedo HM
    Cancer Chemother Pharmacol; 1986; 18(2):124-8. PubMed ID: 3098444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
    Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
    Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cytotoxicity of the methylmelamines.
    Rutty CJ; Abel G
    Chem Biol Interact; 1980 Feb; 29(2):235-46. PubMed ID: 6766359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
    Rutty CJ; Judson IR; Abel G; Goddard PM; Newell DR; Harrap KR
    Cancer Chemother Pharmacol; 1986; 17(3):251-8. PubMed ID: 3091280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in Situ Oxazolidine Formation with Highly Synergistic Cytotoxicity and DNA Cross-Linking in Cancer Cells from Combinations of Doxorubicin and Formaldehyde.
    Barthel BL; Mooz EL; Wiener LE; Koch GG; Koch TH
    J Med Chem; 2016 Mar; 59(5):2205-21. PubMed ID: 26881291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity analysis of the formation of DNA damage induced in human tumor cells by the cyclodisone class of anti-tumor agent.
    Berardini MD; Pacheco DY; Gibson NW
    Anticancer Drug Des; 1991 May; 6(2):119-27. PubMed ID: 2039582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
    Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
    J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: formation of cyclic deoxyguanosine adducts and formaldehyde cross-links.
    Cheng G; Shi Y; Sturla SJ; Jalas JR; McIntee EJ; Villalta PW; Wang M; Hecht SS
    Chem Res Toxicol; 2003 Feb; 16(2):145-52. PubMed ID: 12588185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.
    Judson IR; Rutty CJ; Abel G; Graham MA
    Br J Cancer; 1986 May; 53(5):601-6. PubMed ID: 3087399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.